NCT07720063

Brief Summary

Adolescent non-suicidal self-injury (NSSI) is common, strongly associated with psychiatric comorbidity and an increased risk of future suicide attempt. Although interventions targeting emotion regulation have been shown to reduce NSSI in both adults and adolescents few, are available within routine child and adolescent mental health services (CAMHS). Emotion Regulation for Adolescents (ERA), adapted from an evidence-based adult intervention is a brief group-based treatment designed to increase access to effective, evidence-based care for adolescents with NSSI. A large-scale randomised controlled trial (RCT) is needed to establish its efficacy and strengthen the evidence base for emotion regulation interventions for adolescent NSSI. The overall aim of this project is to increase the availability of evidence-based psychological treatments for adolescent NSSI by developing and evaluating Emotion Regulation for Adolescents (ERA), a novel behavioural and acceptance-based intervention. The main objectives are to establish the efficacy, cost-effectiveness, and long-term outcomes of ERA for adolesent NSSI in two arm RCT comparing ERA with an active control condition (FUNK) as well as to investigate potential mediators such as emotion regulation and self-criticism.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
102mo left

Started Aug 2026

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
26 days until next milestone

Study Start

First participant enrolled

August 17, 2026

Expected
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2032

2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2034

Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

6.4 years

First QC Date

July 17, 2026

Last Update Submit

July 17, 2026

Conditions

Keywords

emotion regulation group therapynon-suicidal self-injury (NSSI)randomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in clinician-rated scores on Deliberate Self-Harm Inventory - Youth Version (DSHI-Y-7)

    Used to assess frequency, abstinence and severity of non-suicidal self-injury. Clinician-rated. Lower scores means better outcome.

    [Time Frame: Baseline; week 12 post baseline; 1 [PRIMARY ENDPOINT]-, 6- and 12-month follow-up.]

Secondary Outcomes (15)

  • Clinical Global Impression - Severity (CGI-S)

    [Time Frame: Baseline; week 12 post baseline; 1-, 6- and 12-month follow-up.]

  • Clinical Global Impression - Improvement (CGI-I)

    [Time Frame: Week 12 post baseline; 1-, 6- and 12-month follow-up.]

  • Children's Global Assessment Scale (CGAS)

    [Time Frame: Baseline; week 12 post baseline; 1-, 6- and 12-month follow-up.]

  • Deliberate Self-Harm Inventory - Youth Version (DSHI-Y-7)

    [Time Frame: Baseline; Mid-treatment: once every week (0-12 weeks post baseline); 1-, 6- and 12-month follow-up.]

  • Borderline Symptom List, supplement (BSL-23, suppl)

    [Time Frame: Baseline; Mid- treatment: once every week (0-12 weeks post baseline); 1-, 6- and 12-month follow-up.]

  • +10 more secondary outcomes

Other Outcomes (3)

  • Child Health Utility 9D (CHU9D)

    [Time Frame: Baseline; 1- and 12-month follow-up.]

  • Trimbos Questionnaire for Costs associated with Psychiatric Illness (TiC-P)

    [Time Frame: Baseline; 1- and 12-month follow-up.]

  • Negative effects questionnaire

    [Time Frame: Week 6; Week 12 post baseline; 1-, 6- and 12-month follow-up]

Study Arms (2)

Emotion Regulation Adolescents (ERA).

EXPERIMENTAL

Manualized 12-week group intervention for adolescents with NSSI and a parallel five-session parent program.

Behavioral: Emotion Regulation Group Therapy for Self-harming Adolescents, ERA

Functional habits for mental health (FUNK)

ACTIVE COMPARATOR

Active comparator: Active Control Condition (FUNK) Manualized psychoeducational group intervention with family participation, individualized safety planning, and weekly risk monitoring.

Behavioral: Functional habits for mental health, FUNK

Interventions

Active comparator: Active Control Condition (FUNK) Participants receive a manualized active control condition FUNK consisting of: 1) ane individual family session to develop a personalized safety plan; 2) five group-based psychoeducation family sessions over 10 weeks, covering sleep, nutrition and physical activity, anxiety, depression and emotions; and 3) weekly suicide risk monitoring.

Functional habits for mental health (FUNK)

Manualized 12-week group intervention for adolescents with NSSI and a parallel five-session parent program. Experimental: ERA Participants receive ERA a 12-week manualized group intervention, targeting NSSI. The intervention focuses on increasing adaptive emotion regulation, reducing impulsive behaviours, and increasing acceptance of difficult emotions with integrated exercises to increase self-compassion and reduce self-criticism. Caregivers participate in a parallel five-session parent group focusing on preventing NSSI contagion, supporting emotion regulation and strengthening adaptive family communication and functioning.

Emotion Regulation Adolescents (ERA).

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may not qualify if:

  • Intellectual disability or a severe psychiatric disorder requiring immediate treatment (e.g., psychosis, bipolar disorder type 1, anorexia nervosa, alcohol/substance dependence) or conditions that prevent participation (e.g., severe social anxiety, selective mutism) Acute suicide risk (i.e., current suicide plans) or recent suicide attempt Previous or ongoing structured emotion regulation treatment involving at least 3 sessions during the past 12 months Previous or ongoing structured emotion regulation treatment (≥3 sessions within past 12 months) Social circumstances preventing participation or require immediate action (e.g., domestic violence, abuse and/or neglect in the family, inpatient care) Ongoing structured psychological treatment targeting NSSI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Self-Injurious Behavior

Interventions

Mental Health

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

HealthPopulation Characteristics

Study Officials

  • Hanna J Sahlin, PhD, Ass Professor

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hanna Sahlin, PhD, Ass Prof

CONTACT

Ann Rosén, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors remain blinded to treatment allocation for all post-treatment and follow-up assessments. Identical assessment procedures and outcome measures are used accross groups to maintain blinding. Participants are reminded, at each assessment, not to disclose allocation. Assessors document any instances of accidental unblinding and and provide a guess of treatment allocation with rationale for their judgement after each assesment to evaluate blinding integrity. In cases of accidental unblinding, a new blinded assessor is assigned to conduct subsequent assessments and provide an independent treatment allocation guess. The proportion of correct guesses will be compared with chance level to assess masking success. Blinding is maintained until completion of the final follow-up assessment (12-month follow-up), and database lock, after which unblinding is performed for analysis.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Interventional Model Description: Single-blind parallel-group randomised controlled trial. Following completion of the primary endpoint assessment, participants in the active control condition may be offered crossover to ERA upon request.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Phd, Associate Professor

Study Record Dates

First Submitted

July 17, 2026

First Posted

July 22, 2026

Study Start (Estimated)

August 17, 2026

Primary Completion (Estimated)

December 31, 2032

Study Completion (Estimated)

December 31, 2034

Last Updated

July 22, 2026

Record last verified: 2026-07